Pet Allergy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2023-2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

Description

The global pet allergy treatment market, which generated a revenue of US$ 2.2 billion in 2024, is projected to expand at a robust CAGR of 8.12%, reaching a substantial size of US$ 3.8 billion by the end of 2031, according to Fairfield Market Research.

Increasing Prevalence of Pet Allergies

As pet ownership grows worldwide, allergies in pets, particularly dogs and cats, are on the rise, leading to discomfort and health issues. Pets can develop allergies to various environmental factors, including pollen, dust mites, certain foods, and more. This can result in symptoms such as itching, sneezing, skin irritations, and digestive problems.

Varied Treatment Options

To address this growing concern, the global pet allergy treatment market offers a range of solutions, including medications, allergen-specific immunotherapy, and hypoallergenic diets. As pet owners become more aware of their furry companions' allergies, the market is expected to expand to meet the demand for effective and safe solutions to alleviate pet allergy symptoms and enhance their overall well-being.

Advancements in Veterinary Allergology

Veterinary allergology has witnessed significant advancements in recent years, paralleling the increasing awareness of allergic diseases in animals. Availability of novel reagents and technologies has led to a deeper understanding of the pathogenesis of allergic diseases in animals, such as dogs and horses.

Market Growth in Key Countries

United States: The United States, accounting for a notable share of the global pet allergy treatment market, experiences demand growth driven by the increasing adoption of pet health insurance. Rising pet ownership and the need for effective allergy relief solutions contribute to market expansion.

China: China sees an uptick in demand due to rising pet ownership and the development of smart AI devices for pets. Increased awareness and monitoring of pets' health drive the need for effective pet allergy treatment in the country.

Germany: Germany's diverse environmental conditions contribute to a higher prevalence of pet allergies. The advanced veterinary healthcare system enables early diagnosis and treatment, fostering demand for allergy treatment options.

Challenges and Obstacles

Despite the market's growth, challenges persist, including limited awareness of pet allergies among owners, high treatment costs, and misconceptions about the causes of pet allergies. Overcoming these obstacles is crucial for continued market expansion.

Competition Landscape

The pet allergy treatment market features a highly fragmented landscape, with numerous competitors offering localized products and services. Businesses are employing strategies such as expansion and innovation to meet the growing demand for pet allergy treatments.

Key Players

Key companies operating in the market include Zoetis Animal Healthcare, Merck and Co Inc., Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, Bayer AG, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Virbac SA, IDEXX Laboratories, Inc., Ceva Sante Animale, Kindred Biosciences, Inc., Phirbo Animal Health, Norbrook Laboratories Limited, Vetiquinol SA, Neogen Corporation, PetIQ, Inc., Huvepharma AD, Chanelle Pharma Group Limited, Kepro, and Biogenesis Bago.

Market Segmentation

The market is segmented by drug class, indication, pet type, route of administration, distribution channel, and region.

By Drug Class:

Antihistamines

Corticosteroids

Immunotherapy

Antibiotics

By Indication:

Allergic Dermatitis

Food Allergy

Fleabite Allergy

Contact Allergy

By Pet Type:

Dogs

Cats

Rodents & Rabbits

By Route of Administration:

Oral

Injectable

Topical

By Distribution Channel:

Veterinary Hospitals

Retail Pharmacies

Online Pharmacies

Others

By Region:

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa

1. Executive Summary

1.1. Global Pet Allergy Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, By Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. Covid-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.8. PESTLE Analysis

3. Global Pet Allergy Treatment Market Outlook, 2018 - 2031

3.1. Global Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Antihistamines
  - 3.1.1.2. Corticosteroids
  - 3.1.1.3. Immunotherapy
  - 3.1.1.4. Antibiotics
3.2. Global Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Allergic Dermatitis
  - 3.2.1.2. Food Allergy
  - 3.2.1.3. Fleabite Allergy
  - 3.2.1.4. Contact Allergy
3.3. Global Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Dogs
  - 3.3.1.2. Cats
  - 3.3.1.3. Rodents and rabbits
3.4. Global Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Oral
  - 3.4.1.2. Injectable
  - 3.4.1.3. Topical
3.5. Global Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. Veterinary Hospitals
  - 3.5.1.2. Retail Pharmacies
  - 3.5.1.3. Online Pharmacies
  - 3.5.1.4. Others
3.6. Global Pet Allergy Treatment Market Outlook, By Region, Value (US$ Bn), 2018 - 2030
- 3.6.1. Key Highlights
  - 3.6.1.1. North America
  - 3.6.1.2. Europe
  - 3.6.1.3. Asia Pacific
  - 3.6.1.4. Latin America
  - 3.6.1.5. Middle East & Africa

4. North America Pet Allergy Treatment Market Outlook, 2018 - 2031

4.1. North America Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Antihistamines
  - 4.1.1.2. Corticosteroids
  - 4.1.1.3. Immunotherapy
  - 4.1.1.4. Antibiotics
4.2. North America Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Allergic Dermatitis
  - 4.2.1.2. Food Allergy
  - 4.2.1.3. Fleabite Allergy
  - 4.2.1.4. Contact Allergy
4.3. North America Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Dogs
  - 4.3.1.2. Cats
  - 4.3.1.3. Rodents and rabbits
4.4. North America Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Oral
  - 4.4.1.2. Injectable
  - 4.4.1.3. Topical
4.5. North America Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. Veterinary Hospitals
  - 4.5.1.2. Retail Pharmacies
  - 4.5.1.3. Online Pharmacies
  - 4.5.1.4. Other
4.6. North America Pet Allergy Treatment Market Outlook, By Country, Value (US$ Bn), 2018 - 2030
- 4.6.1. Key Highlights
  - 4.6.1.1. U.S. Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 4.6.1.2. U.S. Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 4.6.1.3. U.S. Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 4.6.1.4. U.S. Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 4.6.1.5. U.S. Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 4.6.1.6. Canada Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 4.6.1.7. Canada Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 4.6.1.8. Canada Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 4.6.1.9. Canada Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 4.6.1.10. Canada Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
- 4.6.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Pet Allergy Treatment Market Outlook, 2018 - 2031

5.1. Europe Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Antihistamines
  - 5.1.1.2. Corticosteroids
  - 5.1.1.3. Immunotherapy
  - 5.1.1.4. Antibiotics
5.2. Europe Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Allergic Dermatitis
  - 5.2.1.2. Food Allergy
  - 5.2.1.3. Fleabite Allergy
  - 5.2.1.4. Contact Allergy
5.3. Europe Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Dogs
  - 5.3.1.2. Cats
  - 5.3.1.3. Rodents and rabbits
5.4. Europe Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Oral
  - 5.4.1.2. Injectable
  - 5.4.1.3. Topical
5.5. Europe Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Veterinary Hospitals
  - 5.5.1.2. Retail Pharmacies
  - 5.5.1.3. Online Pharmacies
  - 5.5.1.4. Other
5.6. Europe Pet Allergy Treatment Market Outlook, By Country, Value (US$ Bn), 2018 - 2030
- 5.6.1. Key Highlights
  - 5.6.1.1. Germany Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 5.6.1.2. Germany Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 5.6.1.3. Germany Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 5.6.1.4. Germany Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.6.1.5. Germany Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 5.6.1.6. U.K. Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 5.6.1.7. U.K. Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 5.6.1.8. U.K. Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 5.6.1.9. U.K. Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.6.1.10. U.K. Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 5.6.1.11. France Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 5.6.1.12. France Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 5.6.1.13. France Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 5.6.1.14. France Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.6.1.15. France Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 5.6.1.16. Italy Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 5.6.1.17. Italy Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 5.6.1.18. Italy Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 5.6.1.19. Italy Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.6.1.20. Italy Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 5.6.1.21. Russia Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 5.6.1.22. Russia Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 5.6.1.23. Russia Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 5.6.1.24. Russia Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.6.1.25. Russia Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 5.6.1.26. Rest of Europe Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 5.6.1.27. Rest of Europe Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 5.6.1.28. Rest of Europe Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 5.6.1.29. Rest of Europe Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 5.6.1.30. Rest of Europe Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
- 5.6.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pet Allergy Treatment Market Outlook, 2018 - 2031

6.1. Asia Pacific Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Antihistamines
  - 6.1.1.2. Corticosteroids
  - 6.1.1.3. Immunotherapy
  - 6.1.1.4. Antibiotics
6.2. Asia Pacific Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Allergic Dermatitis
  - 6.2.1.2. Food Allergy
  - 6.2.1.3. Fleabite Allergy
  - 6.2.1.4. Contact Allergy
6.3. Asia Pacific Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Dogs
  - 6.3.1.2. Cats
  - 6.3.1.3. Rodents and rabbits
6.4. Asia Pacific Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Oral
  - 6.4.1.2. Injectable
  - 6.4.1.3. Topical
6.5. Asia Pacific Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. Veterinary Hospitals
  - 6.5.1.2. Retail Pharmacies
  - 6.5.1.3. Online Pharmacies
  - 6.5.1.4. Other
6.6. Asia Pacific Pet Allergy Treatment Market Outlook, By Country, Value (US$ Bn), 2018 - 2030
- 6.6.1. Key Highlights
  - 6.6.1.1. China Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 6.6.1.2. China Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 6.6.1.3. China Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 6.6.1.4. China Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.6.1.5. China Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 6.6.1.6. Japan Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 6.6.1.7. Japan Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 6.6.1.8. Japan Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 6.6.1.9. Japan Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.6.1.10. Japan Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 6.6.1.11. South Korea Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 6.6.1.12. South Korea Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 6.6.1.13. South Korea Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 6.6.1.14. South Korea Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.6.1.15. South Korea Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 6.6.1.16. India Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 6.6.1.17. India Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 6.6.1.18. India Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 6.6.1.19. India Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.6.1.20. India Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 6.6.1.21. Southeast Asia Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 6.6.1.22. Southeast Asia Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 6.6.1.23. Southeast Asia Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 6.6.1.24. Southeast Asia Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.6.1.25. Southeast Asia Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 6.6.1.26. Rest of Asia Pacific Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 6.6.1.27. Rest of Asia Pacific Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 6.6.1.28. Rest of Asia Pacific Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 6.6.1.29. Rest of Asia Pacific Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 6.6.1.30. Rest of Asia Pacific Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
- 6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pet Allergy Treatment Market Outlook, 2018 - 2031

7.1. Latin America Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Antihistamines
  - 7.1.1.2. Corticosteroids
  - 7.1.1.3. Immunotherapy
  - 7.1.1.4. Antibiotics
7.2. Latin America Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Allergic Dermatitis
  - 7.2.1.2. Food Allergy
  - 7.2.1.3. Fleabite Allergy
  - 7.2.1.4. Contact Allergy
7.3. Latin America Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Dogs
  - 7.3.1.2. Cats
  - 7.3.1.3. Rodents and rabbits
7.4. Latin America Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Oral
  - 7.4.1.2. Injectable
  - 7.4.1.3. Topical
7.5. Latin America Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Veterinary Hospitals
  - 7.5.1.2. Retail Pharmacies
  - 7.5.1.3. Online Pharmacies
  - 7.5.1.4. Other
7.6. Latin America Pet Allergy Treatment Market Outlook, By Country, Value (US$ Bn), 2018 - 2030
- 7.6.1. Key Highlights
  - 7.6.1.1. Brazil Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 7.6.1.2. Brazil Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 7.6.1.3. Brazil Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 7.6.1.4. Brazil Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 7.6.1.5. Brazil Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 7.6.1.6. Mexico Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 7.6.1.7. Mexico Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 7.6.1.8. Mexico Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 7.6.1.9. Mexico Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 7.6.1.10. Mexico Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 7.6.1.11. Rest of Latin America Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 7.6.1.12. Rest of Latin America Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 7.6.1.13. Rest of Latin America Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 7.6.1.14. Rest of Latin America Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 7.6.1.15. Rest of Latin Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
- 7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pet Allergy Treatment Market Outlook, 2018 - 2031

8.1. Middle East & Africa Pet Allergy Treatment Market Outlook, By Drug Class, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Antihistamines
  - 8.1.1.2. Corticosteroids
  - 8.1.1.3. Immunotherapy
  - 8.1.1.4. Antibiotics
8.2. Middle East & Africa Pet Allergy Treatment Market Outlook, By Indication, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Allergic Dermatitis
  - 8.2.1.2. Food Allergy
  - 8.2.1.3. Fleabite Allergy
  - 8.2.1.4. Contact Allergy
8.3. Middle East & Africa Pet Allergy Treatment Market Outlook, By Pet Type, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Dogs
  - 8.3.1.2. Cats
  - 8.3.1.3. Rodents and rabbits
8.4. Middle East & Africa Pet Allergy Treatment Market Outlook, By Route of Administration, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Oral
  - 8.4.1.2. Injectable
  - 8.4.1.3. Topical
8.5. Middle East & Africa Pet Allergy Treatment Market Outlook, By Distribution Channel, Value (US$ Bn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. Veterinary Hospitals
  - 8.5.1.2. Retail Pharmacies
  - 8.5.1.3. Online Pharmacies
  - 8.5.1.4. Others
8.6. Middle East & Africa Pet Allergy Treatment Market Outlook, By Country, Value (US$ Bn), 2018 - 2030
- 8.6.1. Key Highlights
  - 8.6.1.1. GCC Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 8.6.1.2. GCC Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 8.6.1.3. GCC Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 8.6.1.4. GCC Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 8.6.1.5. GCC Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 8.6.1.6. South Africa Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 8.6.1.7. South Africa Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 8.6.1.8. South Africa Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 8.6.1.9. South Africa Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 8.6.1.10. South Africa Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 8.6.1.11. Egypt Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 8.6.1.12. Egypt Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 8.6.1.13. Egypt Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 8.6.1.14. Egypt Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 8.6.1.15. Egypt Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
  - 8.6.1.16. Rest of Middle East & Africa Pet Allergy Treatment Market By Drug Class, Value (US$ Bn), 2018 - 2030
  - 8.6.1.17. Rest of Middle East & Africa Pet Allergy Treatment Market By Indication, Value (US$ Bn), 2018 - 2030
  - 8.6.1.18. Rest of Middle East & Africa Pet Allergy Treatment Market By Pet Type, Value (US$ Bn), 2018 - 2030
  - 8.6.1.19. Rest of Middle East & Africa Pet Allergy Treatment Market By Route of Administration, Value (US$ Bn), 2018 - 2030
  - 8.6.1.20. Rest of Middle East & Africa Pet Allergy Treatment Market By Distribution Channel, Value (US$ Bn), 2018 - 2030
- 8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Product vs Application Heatmap
9.2. Manufacturer vs Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Zoetis Animal Healthcare
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Merck and Co.Inc. (US)
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Boehringer Ingelheim GmbH
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Elanco Animal Health Incorporated
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Bayer AG
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Vetoquinol S.A.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Dechra Pharmaceuticals PLC
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Virbac SA
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Business Strategies and Development
- 9.5.9. IDEXX Laboratories, Inc.
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Ceva Sante Animale
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development
- 9.5.11. Kindred Biosciences, Inc.
  - 9.5.11.1. Company Overview
  - 9.5.11.2. Product Portfolio
  - 9.5.11.3. Financial Overview
  - 9.5.11.4. Business Strategies and Development
- 9.5.12. Phirbo Animal Health
  - 9.5.12.1. Company Overview
  - 9.5.12.2. Product Portfolio
  - 9.5.12.3. Financial Overview
  - 9.5.12.4. Business Strategies and Development
- 9.5.13. Norbrook Laboratories Limited
  - 9.5.13.1. Company Overview
  - 9.5.13.2. Product Portfolio
  - 9.5.13.3. Financial Overview
  - 9.5.13.4. Business Strategies and Development
- 9.5.14. Vetiquinol SA
  - 9.5.14.1. Company Overview
  - 9.5.14.2. Product Portfolio
  - 9.5.14.3. Financial Overview
  - 9.5.14.4. Business Strategies and Development
- 9.5.15. Neogen Corporation
  - 9.5.15.1. Company Overview
  - 9.5.15.2. Product Portfolio
  - 9.5.15.3. Financial Overview
  - 9.5.15.4. Business Strategies and Development
- 9.5.16. PetIQ, Inc.
  - 9.5.16.1. Company Overview
  - 9.5.16.2. Product Portfolio
  - 9.5.16.3. Financial Overview
  - 9.5.16.4. Business Strategies and Development
- 9.5.17. Huvepharma AD
  - 9.5.17.1. Company Overview
  - 9.5.17.2. Product Portfolio
  - 9.5.17.3. Financial Overview
  - 9.5.17.4. Business Strategies and Development
- 9.5.18. Chanelle Pharma Group Limited
  - 9.5.18.1. Company Overview
  - 9.5.18.2. Product Portfolio
  - 9.5.18.3. Financial Overview
  - 9.5.18.4. Business Strategies and Development
- 9.5.19. Kepro
  - 9.5.19.1. Company Overview
  - 9.5.19.2. Product Portfolio
  - 9.5.19.3. Financial Overview
  - 9.5.19.4. Business Strategies and Development
- 9.5.20. Biogenesis Bago
  - 9.5.20.1. Company Overview
  - 9.5.20.2. Product Portfolio
  - 9.5.20.3. Financial Overview
  - 9.5.20.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations